Select a deal type and sector to view HMT UK mid-market M&A deals:
Search by Keywords Deal Type-
Gen inCode Healthcare
Maven VCTs invest in Gen inCode
HMT LLP advised Maven Capital Partners on their investment in Gen inCode, a genetic testing business specialising in the risk assessment and prediction of cardiovascular disease. Founded in 2018, Gen inCode has developed a range of patented DNA risk assessment products which utilise AI, bioinformatics and a globally recognised clinical evidence base to provide predictive […]
More Details -
Biotherapy Services Ltd Healthcare
Biotherapy Services raises funding from Foresight Group
HMT LLP advised specialist pharmaceutical biotech company Biotherapy Services Ltd on their Series A fundraising. Foresight VCT invested £3 million to support the growth of the business supplemented by further investment from existing and new private investors. BTS is a clinical stage, Biopharmaceutical company developing and delivering novel autologous regenerative therapies, currently in clinical development […]
More Details